|1.||WO||WO/2013/074050 - MAGNETIC DIFFUSIONAL PATCH||23.05.2013||
|PCT/TR2012/000163||METUAS MEDIKAL SAĞLIK HIZMETLERI DANIŠMANLIK IHRACAT ITHALAT LIMITED ŞIRKETI||DURMAZ, Tuba Çalik|
The invention relates to a diffusional magnetic patch, which is a medical device for application in the treatment of disc hernia and sports injuries, comprising a special formulation that acts mechanically with diffusional effect.
|2.||WO||WO/2013/074046 - PHARMACEUTICAL FORMULATIONS COMPRISING ISOFLAVONE||23.05.2013||
|PCT/TR2012/000119||BILGIC, Mahmut||BILGIC, Mahmut|
The present invention relates to formulations comprising at least one component belonging the group of isoflavones, preparation methods and area of use thereof.
|3.||WO||WO/2013/074047 - SAFETY LOCKING MECHANISM FOR THE MULTI-CONNECTION MEMBER (MANIFOLD) CONTROLLING THE FLUID PASSAGES||23.05.2013||
||PCT/TR2012/000123||TAMSAN BAGLANTI ELEMANLARI YEDEK PARCA VE MAKINA EKIPMANLARI TURIZM INSAAT SANAYI VE TICARET ANONIM SIRKETI||TAMER, Rahmi|
The invention relates to a safety locking mechanism for the multi-connection member (manifold), comprising a lock arm (15) providing motion manually to a camshaft (13) and a safety lock pin (14) positioned into the assembly housing (20) within the camshaft (13) and fitting into the lock housing (18) of a drive shaft (12) while the manifold is in the locked position.
|4.||WO||WO/2013/074048 - TABLET FORMS COMPRISING QUETIAPINE FUMARATE||23.05.2013||
|PCT/TR2012/000129||BILGIC, Mahmut||BILGIC, Mahmut|
The present invention relates to formulations formulated in tablet form comprising quetiapine fumarate and preparation thereof.
|5.||WO||WO/2013/074051 - SYSTEM FOR MOVING A PRINT HEAD||23.05.2013||
|PCT/TR2012/000195||MUSTAFA, Sagbili||MUSTAFA, Sagbili|
The invention relates to a two-stage motion system that draws the print head in thermal transfer printers close to the printing surface for the printing process and away from it at the end of the printing process.
|6.||WO||WO/2013/074049 - MICRONIZED METFORMIN||23.05.2013||
|PCT/TR2012/000153||BILGIC, Mahmut||BILGIC, Mahmut|
The present invention relates to pharmaceutical compositions comprising metformin that shall be used in the treatment of type 2 diabetes.
|7.||WO||WO/2013/070176 - A METHOD FOR RECYCLING WASTE THERMOPLASTIC MATERIALS AND USING THIS RECYCLED THERMOPLASTIC IN COMPOSITE MATERIAL PRODUCTION||16.05.2013||
|PCT/TR2011/000265||GUVEN, Ali Hakan||GUVEN, Ali Hakan|
This invention is related to a method for production of high strength and low cost thermoplastic composite materials by processing and treating waste plastic materials with some minerals. The object of the invention is to embody a recycling method wherein it contains high amounts of additives and therefore composite materials with high strength properties are obtained. Another object of the invention is to embody a recycling method wherein high amounts of additives are used in the production and the machines used in the production are not damaged.
|8.||WO||WO/2013/066277 - SYNERGIC COMPOSITIONS||10.05.2013||
|PCT/TR2012/000152||BILGIC, Mahmut||BILGIC, Mahmut|
The present invention relates to pharmaceutical compositions comprising nateglinide and metformin hydrochloride that shall be used in the treatment of type-2 diabetes.
|9.||WO||WO/2013/066279 - SOLID DOSAGE FORMS COMPRISING EZETIMIBE||10.05.2013||
|PCT/TR2012/000173||BILGIC, Mahmut||BILGIC, Mahmut|
The present invention relates to pharmaceutical formulations comprising an active agent having solubility problems; and the production methods and use of these formulations.
|10.||WO||WO/2013/066280 - WATER SOLUBLE ANTIPSYCHOTIC FORMULATIONS||10.05.2013||
|PCT/TR2012/000181||BILGIC, Mahmut||BILGIC, Mahmut|
The present invention relates to water soluble formulations comprising effective amounts of olanzapine or a pharmaceutically acceptable salt thereof; and production methods thereof.